Evolus Inc (EOLS) Stock Price, Quote, News & History

EOLSNASDAQ
$6.27
-0.25-3.83%
At close: Jul 14, 5:00 PM EST
$6.27
N/A
After Hours: 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-36.59M
Investing Cash Flow (TTM)
-8.28M
Financing Cash Flow (TTM)
26.59M
Free Cash Flow (TTM)
-44.87M
Capital Expenditure (TTM)
-8.28M
Net Change in Cash (TTM)
-18.28M

Analyst Trends and Forecast

1
Jan
1
Feb
1
Mar
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$543.83M
PE Ratio (TTM)
-
PE Ratio (FWD)
59.17
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.40
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-10.14%
Earnings Yield % (FWD)
1.69%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.44

Company Debt

Total Debt
$156.41M
LT Debt
$156.41M
LT Debt Issuance (TTM)
$35.00M
LT Debt Repayment (TTM)
-$19.00K
Total Cash
$49.79M
Debt to Equity
-
Issuance of Debt (TTM)
$34.98M
Repayment of Debt (TTM)
-$19.00K

Key Statistics

Open
$6.58
Close
$6.27
Volume / Avg.
567.72K / 838.82K
Day Range
$6.24 - $6.62
52 Wk Range
3.86 - 10.20
Market Cap
$412.91M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
39
Short Interest
9.25%
Days to Cover
7.3

About

Sector
Health Care
Industry
Pharmaceuticals
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and inje...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Evolus (EOLS) stock?

A

You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Evolus (EOLS) competitors?

A

There are no as such competitors for Evolus.

Q

What is the forecast, or price target, for Evolus (EOLS) stock?

A

Evolus has a consensus price target of $17.40.

Q

What is the current price for Evolus (EOLS)?

A

The stock price for Evolus (NASDAQ: EOLS) is $6.27 last updated July 14, 2026 at 4:00 PM EDT.

Q

Does Evolus (EOLS) pay a dividend?

A

There are no upcoming dividends for Evolus.

Q

When is Evolus (NASDAQ:EOLS) reporting earnings?

A

Evolus does not have any upcoming earnings scheduled.

Q

Is Evolus (EOLS) going to split?

A

There is no upcoming split for Evolus.

Q

What sector and industry does Evolus (EOLS) operate in?

A

Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.